US 8415370
Spiro-oxindole compounds and their uses as therapeutic agents
granted A61PA61P1/00A61P1/02
Quick answer
US patent 8415370 (Spiro-oxindole compounds and their uses as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P1/04, A61P11/00